Analyst Insights - Digital Health Posts
Read our Analysts’ insights and expert opinions on the latest healthcare technology industry developments and market trends. Signify Research provides both free insights and premium insights which are only available to subscribers of "Signify Premium Insights".
Click on the premium insights link below to filter for just the premium content.
Early Warning for Sepsis from Bayesian Health – Advances of AI in Clinical Care Continue
8th September 2022 – US-based Bayesian Health recently announced the publication of clinical evidence to support its AI-driven early-warning clinical decision support platform for Sepsis detection.
World Ultrasound Market to Remain Flat in 2022 After Large 2021 Recovery
7th September 2022 – In 2021, the global ultrasound market enjoyed strong uplift after the disruption caused by the Covid-19 pandemic in 2020. However, looking ahead, growth prospects appear to be more muted.
Signify Premium Insight: Few Reasons to Smile at Carestream’s Kodak Moment
Signify Premium Insights Subscription Required
6th September 2022 – Carestream Health has entered Chapter 11 bankruptcy. On the surface, the future looks hard for the company, but are there any reasons to be hopeful?
Will 2023 be the Year of Digital Pathology for US Labs?
09th September 2022 – Will 2023 be the Year of Digital Pathology for US Labs? Here is our take on what the recent announcement of 13 new digital pathology add-on codes means for the digital pathology market.
Signify Premium Insight: Screening Marks the Next Step in Intelerad’s Grand Ambition
Signify Premium Insights Subscription Required
2nd September 2022 – Intelerad has continued its acquisition streak with the purchase of PenRad Technologies, a breast and lung screening specialist. The move will differentiate the IT vendor from many of its peers, but, will it help Intelerad seal more deals.